We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.41%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$16.2B
AUM Growth
+$1.63B
Cap. Flow
+$894M
Cap. Flow %
5.51%
Top 10 Hldgs %
15.16%
Holding
2,286
New
215
Increased
1,251
Reduced
646
Closed
120

Sector Composition

Rank Sector Weight
1 Energy 9.92%
2 Technology 7.94%
3 Healthcare 7.8%
4 Financials 7.55%
5 Industrials 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTI icon
201
British American Tobacco
BTI
$128B
$17.9M 0.11%
300,794
+38,548
+15% +$2.26M
AXP icon
202
American Express
AXP
$233B
$17.8M 0.11%
187,340
+5,976
+3% +$539K
DOC icon
203
Healthpeak Properties
DOC
$14.9B
$17.7M 0.11%
470,896
-6,626
-1% -$249K
AMAT icon
204
Applied Materials
AMAT
$411B
$17.7M 0.11%
786,096
+83,864
+12% +$1.71M
CAM
205
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
$17.5M 0.11%
259,144
+11,168
+5% +$720K
MAT icon
206
Mattel
MAT
$4.32B
$17.5M 0.11%
449,586
-20,564
-4% -$798K
AEE icon
207
Ameren
AEE
$30.3B
$17.5M 0.11%
428,219
+48,900
+13% +$1.95M
TE
208
DELISTED
TECO ENERGY INC
TE
$17.4M 0.11%
942,953
+62,143
+7% +$1.09M
DE icon
209
Deere & Co
DE
$163B
$17.4M 0.11%
192,405
-24,033
-11% -$2.21M
NUE icon
210
Nucor
NUE
$59.5B
$17.4M 0.11%
352,927
-13,661
-4% -$701K
FVD icon
211
First Trust Value Line Dividend Fund
FVD
$8.33B
$17.1M 0.11%
746,353
+216,932
+41% +$4.84M
CERN
212
DELISTED
Cerner Corp
CERN
$17.1M 0.11%
330,806
+42,138
+15% +$2.22M
NFX
213
DELISTED
Newfield Exploration
NFX
$17M 0.1%
383,913
-89,421
-19% -$3.21M
CAH icon
214
Cardinal Health
CAH
$55.2B
$16.9M 0.1%
245,879
+46,928
+24% +$3.19M
DFS
215
DELISTED
Discover Financial Services
DFS
$16.5M 0.1%
265,445
+48,171
+22% +$2.81M
FEP icon
216
First Trust Europe AlphaDEX Fund
FEP
$526M
$16.4M 0.1%
472,709
+40,486
+9% +$1.43M
SHM icon
217
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.46B
$16.3M 0.1%
334,992
+32,577
+11% +$1.58M
PII icon
218
Polaris
PII
$4.02B
$16.3M 0.1%
124,800
+432
+0.3% +$57.2K
CHKP icon
219
Check Point Software Technologies
CHKP
$12.6B
$16.1M 0.1%
240,776
+45,518
+23% +$2.99M
IP icon
220
International Paper
IP
$21.9B
$16.1M 0.1%
342,356
+85,149
+33% +$3.73M
VCSH icon
221
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.6B
$16.1M 0.1%
200,618
+4,686
+2% +$376K
GD icon
222
General Dynamics
GD
$103B
$16M 0.1%
137,695
-97,852
-42% -$11.1M
BAX icon
223
Baxter International
BAX
$14.5B
$15.7M 0.1%
400,464
+78,762
+24% +$3.15M
CNC icon
224
Centene
CNC
$31.5B
$15.7M 0.1%
828,116
-98,824
-11% -$1.7M
MPC icon
225
Marathon Petroleum
MPC
$89.6B
$15.5M 0.1%
398,316
+131,028
+49% +$5.8M

Similar funds

Raymond James & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Raymond James & Associates held 2,286 positions worth $16.2B, up 11% from $14.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $894M of net new capital in Q2 2014, opening 215 new positions and adding to 1,251 existing holdings. Its largest new stake was Vanguard Total International Bond ETF: 174,739 shares worth $8.98M.

By sector, the portfolio is most concentrated in Energy at 9.9% of assets, up from 9.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was AstraZeneca, an estimated $38.6M trimmed.

  • Raymond James & Associates's largest Q2 2014 buy was Vanguard Total International Bond ETF: 174,739 shares worth $8.98M.
  • Raymond James & Associates added most to iShares MSCI EAFE ETF in Q2 2014, an estimated $38.2M increase.
  • Raymond James & Associates's biggest Q2 2014 reduction was AstraZeneca, cutting an estimated $38.6M.
  • Raymond James & Associates fully exited Weatherford International plc in Q2 2014, selling an estimated $20.6M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $16.2B portfolio in Q2 2014.
  • Raymond James & Associates opened 215 new positions and closed 120 in Q2 2014.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $16.2B.

Based on Raymond James & Associates's 13F filing for Q2 2014, filed 13 Aug 2014.